Author: Emma Yasinski

Emma Yasinski

I am a freelance science and medical journalist, fascinated by how the scientific process leads to incredible discoveries, but also can lead to publication bias leaning toward positive findings and minimizing negatives. With a bachelor’s degree in neuroscience from Lafayette College and a Master’s in Science and Medical Journalism from Boston University, I’ve written about clinical trial transparency, organ donation, and basic molecular biology for publications like The Scientist, The Atlantic, Undark.org, Kaiser Health News, and more. At MedShadow, I research and write about the sometimes unexpected ways that medicines can affect us, and what we can do if and when it does.

When pregnant, chances are you will have a lot of questions. One of them shouldn’t be “can I take this drug while pregnant,” but sadly research is often lacking in this topic. Tylenol While Pregnant In the last week of September 2021, a group of more than 90 doctors and researchers published a call to action, cautioning against the liberal use of Tylenol (acetaminophen) during pregnancy. The studies suggested that exposure to the drug could increase the risk of a baby having neurodevelopmental, reproductive, and urogenital disorders. The authors added, however, that Tylenol has long been considered one of the…

Read More

If you have heard about the latest craze of taking the supplement known as Ashwagandha for anxiety, you are not alone. There is certainly a buzz around this popular supplement. But what exactly is it, and what can ashwagandha do for you? Todd Miller had been taking Wellbutrin, an antidepressant, when he decided to add ashwagandha to his regimen about two years ago. He doesn’t remember where he heard about ashwagandha, but he says, “I always felt like [wellbutrin] made me sort of sluggish and slow.”  With ashwagandha, he says, he not only feels that his depression is managed, but…

Read More

People on dialysis for kidney disease are 100 time more likely than others to get staph dangerous hospital- acquired infections in their blood. Nearly 15,000 dialysis patients got blood stream infections in 2020, a third of which were staph (infections of a bacteria called Staphylococcus aureus). While the number of infections has decreased since 2014, the risk remains, and disparities are prevalent. Black and Hispanic patients are more likely than their white counterparts on dialysis to get a staph in their bloodstream, according to a Centers for Disease Control and Prevention (CDC) report published February 6, 2023. You’ve been admitted…

Read More

When Pat (now 71) was in her 40s, her vaginal dryness became so severe that the vaginal tissue would flare with even a gentle wipe. She’d been exposed to a drug called DES (diethylstilbestrol) when she was in utero, which caused myriad health issues as she grew up, and was likely behind the dryness. For her, coconut oil made a huge difference. “If only I had known I was not alone with this personal issue,” she says. Vaginal dryness is likely more common than you think. It can affect women of any age, but is especially prevalent among those who…

Read More

​Early in Dee Mangin’s career as a primary-care physician, she noticed that many people, especially older adults, were prescribed large numbers and doses of drugs, which, in some cases, might actually be detracting from their health rather than improving it. Then, she realized that even when polypharmacy (being prescribed five or more medications simultaneously) was recognized as a problem, there wasn’t any systematic way to help patients and healthcare providers assess which medicines might be most effective in a lower dose or discontinued altogether.  Mangin is an MBChB (the New Zealand equivalent of an MD) and DPH (doctor of public…

Read More

In 2018, two young men were found dead in their respective bathrooms in Texas after using a concentrated powder form of tianeptine.  Tianeptine is an antidepressant prescribed in Europe, Asia and South America. It’s banned in the US, but it’s found its way here. The Food and Drug Administration (FDA) issued a warning about the drug’s risks in 2018. Then in February 2022, the agency put out a new warning after scientists found a large increase in calls to poison control centers related to tianeptine poisoning. What is Tianeptine? Tianeptine, sold under the brand names of Coaxil and Stablon, is…

Read More

Angela Ridgel, PhD, an exercise physiologist at Kent State University, usually helps patients exercise at the gym, while studying how it might improve their cognition and brain health. But many exercise routines on land, such as aerobic or stretching ones, for example, can be challenging for people with multiple sclerosis (MS), she says. “When you’re doing exercise [on] land, which is what we mostly do in my lab, that would have a tendency to make MS patients overheat and then exacerbate their symptoms,” she adds. So she teamed up with a doctor who specializes in working with MS patients to…

Read More

When Lily was diagnosed with cervical cancer at age 27, she blamed herself. “Why hadn’t I taken care of myself properly?” she thought. She had regularly skipped her annual Pap smears—a common procedure, in which the doctor collects cells from the vagina wall to test for signs of cervical cancer. “I didn’t think I needed to go,” she said. But when she started bleeding and experiencing daily pelvic pain, she finally visited her OB/GYN and found out that she had cervical cancer. She’s been treated, but regrets having postponed screening because the disease left her infertile. Lily is now an…

Read More

A new chemotherapy drug promises to treat some patients with pediatric acute lymphoblastic leukemia (ALL) who have been unable to take the other two other chemo medicines because one can cause allergic reactions and the other is frequently in short supply.  This summer, the Food and Drug Administration (FDA) fast-tracked the approval of Rylaze, a newer version of the chemo drug Erwinaze to treat ALL (leukemia) , made by Jazz Pharmaceuticals, which was previously distributed Erwinaze. The agency approved Rylaze based on an ongoing Phase 2/3 trial of about 102 patients, with an average age of 10.  The rare disease…

Read More

May 26 Update: Only 62.6% of patients taking methotrexate, an immunosuppressant drug used in some cancer patients, mounted an effective antibody response to Pfizer’s vaccine, according to a study Stephanie, a Stage 4 endometrial cancer patient who has undergone both chemotherapy and immunotherapy since 2019, has been especially cautious throughout the pandemic. “We know how deadly this virus is, especially for older people and those who are immunocompromised,” like herself, she says. “And if not lethal, the complications for Covid-19 survivors are severe.”  The jury is still out on how exactly the COVID-19 vaccine affects cancer patients. Yet some studies point…

Read More